Lisa Molz
VP of Research
Professional Overview
Lisa Molz is an accomplished biopharmaceutical executive with over 20 years of experience driving research and development initiatives in the life sciences industry. As the VP of Research at Avilar Therapeutics, she oversees the company's innovative drug discovery and development programs, leveraging her expertise in translational biology and clinical strategy to advance novel therapeutics.
Experience Summary
Current Role
In her current role as VP of Research at Avilar Therapeutics, Lisa is responsible for leading the company's research efforts, which focus on developing cutting-edge therapies for rare and complex diseases. She manages a team of scientists and collaborates cross-functionally to design and execute research studies, optimize drug candidates, and ensure seamless progression through the drug development pipeline. Under her leadership, Avilar has made significant strides in advancing its pipeline, with several promising drug candidates in various stages of clinical evaluation.
Career Progression
Prior to joining Avilar, Lisa held senior research roles at leading biopharmaceutical companies, including Mitobridge, Navitor Pharmaceuticals, FORMA Therapeutics, GPC Biotech, and Genetica. Throughout her career, she has demonstrated a strong track record of driving impactful research initiatives, leading multidisciplinary teams, and delivering tangible results that have advanced the understanding and treatment of complex diseases.
Academic Background
Lisa holds a Ph.D. in Molecular Biology from the University of Massachusetts and a Bachelor of Science degree in Biology from the University of Vermont. Her doctoral research focused on the development of innovative therapeutic strategies for mitochondrial disorders, laying the foundation for her expertise in translational biology.
Areas of Expertise
- Translational biology and drug discovery
- Preclinical and clinical development strategy
- Mitochondrial biology and rare disease research
- Cross-functional team leadership and collaboration
- Scientific communication and stakeholder engagement
Professional Impact
Throughout her career, Lisa has made significant contributions to the field of biopharmaceutical research. She has co-authored numerous peer-reviewed publications and presented her work at prestigious scientific conferences, sharing insights and advances that have influenced the broader scientific community. Additionally, her research has led to the development of several drug candidates that have entered clinical trials, demonstrating her ability to translate scientific discoveries into potential therapies.
Conclusion
With her exceptional track record, deep industry expertise, and collaborative leadership style, Lisa Molz is a highly respected biopharmaceutical executive who continues to drive innovation and make a meaningful impact in the life sciences sector. As the VP of Research at Avilar Therapeutics, she is well-positioned to guide the company's research efforts and contribute to the development of groundbreaking therapies that address unmet medical needs.
